Performing a gene and cell therapy trial for heart attack patients: an interview with Duncan Stewart
In this interview, Dr. Duncan Stewart from the Ontario Institute for Regenerative Medicine discusses his ongoing ENACT-AMI trial studying angiogenic cell therapy to promote repair after a massive heart attack using eNOS-enhanced EPCs.
In this interview, filmed at the 2018 annual meeting of the International Society of Cell and Gene Therapy (ISCT)(Montreal, QC, Canada), Dr. Duncan Stewart from the Ontario Institute for Regenerative Medicine discusses his ongoing ENACT-AMI trial studying angiogenic cell therapy to promote repair after a massive heart attack using eNOS-enhanced EPCs. Duncan also shares his thoughts on whether regenerative medicine has lived up to its hype.
Learn more about: